Are you looking to invest in a stable, high-growth healthcare asset with a strong brand presence in South India? Lakeshore Hospital & Research Centre (now VPS Lakeshore Hospital) is one of Kerala's largest and most trusted multi-super-specialty hospitals. With world-class infrastructure, a growing medical tourism footprint, and solid financial fundamentals, it presents a compelling opportunity in the unlisted healthcare space.

A Legacy of Excellence:

• Founded: 1996 by Dr. Philip Augustine; operational since January 2003 .
• Location: NH-66 Bypass, Nettoor, Kochi, Kerala – strategically located with easy access to the airport and railway station .
• Accreditations: NABH (National Accreditation Board for Hospitals) accredited, ensuring rigorous quality and patient safety standards .
• Part of VPS Healthcare: Managed by the international VPS Healthcare group, which operates over 25 hospitals and 120 clinics across Europe, the Middle East, and India .

Infrastructure & Capacity:

• Bed Capacity: Approximately 470–650 beds, making it one of the largest tertiary care hospitals in Kerala .
• Advanced Facilities: Over 10 operation theatres, 43 intensive care units, 3T MRI, 64-slice CT scan, and a full digital imaging suite .
• Unique Services: Air, water, and surface ambulance services (recognized by Limca Records), helipad, automated pharmacy, and 24/7 lab services .

Comprehensive Medical Specialties:

Lakeshore offers over 30 clinical departments, including:

• Cardiology & Cardiovascular Surgery
• Neurology & Neurosurgery
• Oncology (Medical & Surgical)
• Gastroenterology & Hepatology
• Organ Transplantation: Liver, Kidney, and Bone Marrow Transplant programs. The hospital performed Kerala's first living-donor liver transplant .
• Orthopaedics: Joint replacement, sports medicine – introduced Kerala's first robotic knee replacement system .
• Nephrology & Urology, Pulmonology, Endocrinology, Pediatrics & Neonatology, Obstetrics & Gynecology, and more .

Awards & Recognition:

• Guinness World Record: For the largest model of a human organ ('HEART' installation) .
• Best Multispecialty Hospital in Kerala – Times Health Excellence Awards 2017 .
• Best Hospital for Organ Transplantation – India Health Summit Awards 2019 .
• Top Private Hospital in South India – CIMS Healthcare Excellence Awards 2020 .
• Excellence in Patient Safety and Quality – NABH Awards 2022 .

Medical Tourism & International Patient Reach:

Lakeshore has a dedicated International Patient Division, assisting with visas, transfers, interpreters, and cashless insurance tie-ups. Foreign patient volume grew substantially – from ~6,008 in FY22 to ~20,047 in FY23, highlighting its growing appeal to patients from the Middle East, Europe, and Asia .

Financial Performance Overview (FY21-FY24):

The hospital has demonstrated strong financial discipline and growth:

Key Financial Ratios:

• P/E Ratio: ~18.86x (as of recent data)
• P/B Ratio: ~2.02x
• Book Value: ₹41 per share
• Debt to Equity: 0 (virtually debt-free)
• ROE: 11%

Shareholding Pattern:

• Dr. Shamsheer Vayalil Parambath (Chairman, VPS Healthcare): ~42.6%
• Mr. Yusuff Ali M.A. (LuLu Group): ~18.8%
• Other Investors: ~38.58%

Strengths & Growth Drivers:

• Strong Brand & Clinical Excellence: Renowned for high-end specialties and complex procedures like organ transplants.
• Growing Medical Tourism: Rising foreign patient inflow adds a high-margin revenue stream.
• Diversified Revenue Base: Multi-specialty coverage ensures breadth and stability.
• Promoter Strength: Backed by VPS Healthcare and marquee investor Yusuff Ali, providing credibility and scale.
• Debt-Free Balance Sheet: Low financial risk and strong downside protection.
• Research & Training: Runs DNB programs and clinical research, adding long-term value and cost synergies .

Risks & Considerations:

• Liquidity Risk: As an unlisted company, shares trade over-the-counter (OTC) with limited daily liquidity. Exit via IPO or strategic sale is the primary realization event.
• Regulatory Risk: Healthcare is subject to strict regulations; transplant programs can attract scrutiny.
• Competition: Faces competition from other large chains like Amrita, Aster, and Apollo in South India.
• Past Controversy: An organ donation case from 2009 led to criminal charges in 2023; while historical, it highlights ethical scrutiny risks in transplant medicine .

Valuation & Opportunity:

Currently, Lakeshore Hospital unlisted shares are available at approximately ₹103–110 per share , with a market capitalization of ₹830–1,350 crore . At a P/E of ~18–30x, it is reasonably valued for a stable healthcare play, especially given its debt-free status and strong institutional backing.

For investors seeking exposure to India's growing healthcare and medical tourism story, Lakeshore Hospital offers a unique combination of clinical reputation, financial stability, and long-term growth potential.

Ready to Add a Premier Healthcare Asset to Your Portfolio?

Buy Unlisted Shares of VPS Lakeshore Hospital Ltd exclusively through Unlisted Network.

Invest in a trusted institution with a legacy of care, innovation, and financial strength.